There is simply no replacement for the shared communal experience. W4Humanity's TRUSTPASS system is essential to the livelihoods of promoters and businesses that depend on safe mass-gatherings.
HOUSTON (PRWEB) November 16, 2020
Urgent. Revolutionary. Lifesaving. Wellness 4 Humanity (W4Humanity.com) is using biotechnology and life science in a paradigm shift to help propel humanity forward in our post-COVID-19 world. With the launch of the first Spread Love Not Covid (SLNC) U.S. Tour, Wellness 4 Humanity is making it possible for mass social gatherings to resume in a medically safe and efficient way. The Spread Love Not Covid Tour is the first and only electronic dance music (EDM) tour to utilize F.D.A. E.U.A.-certified biotechnology and the TRUSTPASS system to facilitate the seamless operation of mass live entertainment events. The management team at W4Humanity has over 50 years combined experience producing live music events and they were actively working in the entertainment industry prior to the COVID-19 pandemic.
There is simply no replacement for the shared communal experience.
Simply put, theres simply no replacement for the shared communal experience the live entertainment space has to offer. The temporary halt of mass gatherings has been most acutely experienced by those who work and play in the live entertainment sector. In the U.S. alone, the live entertainment, hospitality and restaurant sectors have an outsize impact on the overall economy and its these same sectors that have been disproportionately affected by the widespread cancellations due to the global COVID-19 pandemic. In the hugely popular music genre of EDM (electronic dance music) alone, the impact is being felt by workers and consumers of outdoor music festivals (i.e. Coachella, Ultra Music Festival, Electric Daisy Carnival. Miami Music Week, Tomorrowland, Electric Zoo and countless others); nightclubs and bars; hotels, convention centers and casinos; catering halls and other venues that normally host special events. Ask any typical young person what he or she misses the most and chances are that the response will include an allusion to outdoor music festivals or EDM nightclub events that he or she had planned on attending this summer (but which were suddenly canceled).
Humans are social creatures. The shared communal experience, centered around music & entertainment, is woven into our DNA.
What if you could open an app on your smartphone with a code that would not only act as your entry into your favorite nightclub or music festival, but also be your insurance that, once inside, every person in attendance would also be COVID-19-negative? W4Humanity makes it not only possible, but essential to the livelihoods of promoters and businesses that depend on safe mass-gatherings. Socially distanced drive-ins simply dont cut it with music fans. Isolated partying in ones parked vehicle, yards away from the nearest festivalgoer, is a lame facsimile of the authentic festival experience music-lovers so desperately crave. Theres no internet livestream that could ever replace the experience of an actual, in-person gathering.
How the process works.
Because not everyone will take a COVID-19 vaccine even after vaccines become widely available, W4Humanity makes it easy and financially profitable for live entertainment organizers to open back up with W4Humanitys patented TRUSTPASS system of rapid onsite testing.
The Spread Love Not Covid Tour aims to bring the first system of fully scalable, rapid onsite COVID-19 testing directly to the hospitality and live entertainment sector by implementing a system of surveillance testing known as TRUSTPASS. The TRUSTPASS system encompasses a seamless four-step process that includes:
Wellness 4 Humanity has the answer.
Wellness 4 Humanitys client roster includes Fortune 100 entities in the travel and hospitality, retail and entertainment industries, among other sectors. Clients in the hospitality and media sectors include: the Marriott Marquis Houston and the Hilton Houston; Orangetheory Fitness; WAGA-TV, FOX-5 TV Atlanta; Tyler Perry Studios in Atlanta; and Magnum P.I. in Los Angeles. Private clients for Wellness 4 Humanitys white-glove concierge service for in-home/in-office testing include: David J. Long (CEO & Co-Founder of Orangetheory Fitness) and his family; the multi-Platinum singer/songwriter, producer and actor, Post Malone; Tony Hsieh (former CEO of Zappos), and others. W4Humanity is even assisting major chains including Houstons 25-door Legacy Clinics (https://www.legacycommunityhealth.org/) process their employees COVID-19 tests. Other pharmacies regularly refer their customers to W4Humanity because of its ability to process tests faster than other established laboratories like Quest Diagnostics. Private companies, including large attorneys offices, are calling on W4Humanity at an ever-increasing rate to test their employees and clients. Fixed walk-in locations for W4Humanity can be found at Simon Centers shopping malls and other locations throughout Colorado, Utah, Georgia, California, Florida, Texas (at The Galleria Houston) and Hawaii, with more states constantly being added. What sets W4Humanity apart from established laboratories is that W4Humanity has a highly skilled network of medical professionals ready-to-deploy throughout the U.S. to any event or gathering where requested. All W4Humanity staff members meet rigorous medical certification and are at minimum licensed health technicians (i.e. phlebotomists, etc.) reporting to the companys National Laboratory Director and State Medical Directors. To date, W4Humanity is the only privately-owned and operated, F.D.A. E.U.A.-certified company equipped to manufacture, market and deploy its proprietary PCR tests around the U.S. and world.
Wellness4 Humanity allows businesses that rely on mass-gatherings to re-open and operate safely. The company is using this tour as a showcase for health, safety and innovation where people gather. The TRUSTPASS system will allow social gatherings in permanent venues (i.e. nightclubs, catering halls, hotels, convention centers, shopping malls, bars/lounges, restaurants, etc.) as well as temporary venues (i.e. open-air music festivals, culinary festivals, film festivals, sporting events, etc.) to flourish once again.
Download Artwork & Press Images - https://we.tl/t-shic1pnTu8
Stream NOA|AON feat. Hart Sawyer, Sunshine, the official theme song for SLNC Tour - https://open.spotify.com/album/0nGymNzT6PSoBxQaRr69Df?highlight=spotify:track:37x4nTEhyiYTyJAbopWmAg
For more information visit - https://www.w4humanity.com/
https://m.facebook.com/wellness4humanity/ http://www.facebook.com/spreadlovenot https://instagram.com/w4humanity?igshid=1jv08tlhoa30w https://instagram.com/spreadlovenotcom?igshid=1eyyt9sf4zgd0 https://www.w4humanity.com/
PRESS CONTACT (U.S.)attention: EMILY TANEMILY TAN MEDIA RELATIONSEmilyTan@EmilyTanMediaRelations.com+1(917) 318-3758
###
Share article on social media or email:
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Yahoo Finance - November 16th, 2024
- Department of Biotechnology Launches Webinar Series on Biomanufacturing and Biofoundry Initiative - IBG NEWS - November 16th, 2024
- Multimodal scanning of genetic variants with base and prime editing - Nature.com - November 16th, 2024
- NEW INITIATIVE BY THE ITALIAN EMBASSY IN WASHINGTON ON BIOTECHNOLOGY WITH THE MILKEN INSTITUTE AND LEADING RESEARCHERS AND INDUSTRY EXPERTS -... - November 16th, 2024
- Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at... - November 16th, 2024
- Albany State offers new Master of Science in Integrated Biotechnology program - The Albany Herald - November 16th, 2024
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Benzinga - November 16th, 2024
- iNtRON Biotechnology (KOSDAQ:048530) Is In A Strong Position To Grow Its Business - Simply Wall St - November 16th, 2024
- PDS Biotechnology Highlights Clinical Progress and Q3 Results - TipRanks - November 16th, 2024
- We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance - November 16th, 2024
- Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St - November 16th, 2024
- APHIS Announces Final Notice on Additional Exemptions for the Movement of Organisms Modified or Produced Through Genetic Engineering - USDA APHIS - November 16th, 2024
- Adaptimmune nears second approval for TCR-T therapy - European Biotechnology News - November 16th, 2024
- Lundbeck reports 18% revenue growth in third quarter - The Pharma Letter - November 16th, 2024
- BioNTech to boost oncology offering with buy of Biotheus - The Pharma Letter - November 16th, 2024
- Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - November 16th, 2024
- WPI Receives Federal Funding to Address Anticipated Demand for Biology and Biotechnology Professionals and Educators - WPI News - November 3rd, 2024
- Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research - College of Computer, Mathematical, and Natural Sciences - November 3rd, 2024
- PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts - MarketBeat - November 3rd, 2024
- COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved - Renewable Matter - November 3rd, 2024
- Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets - PR Newswire - November 3rd, 2024
- Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter - November 3rd, 2024
- Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter - November 3rd, 2024
- AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter - November 3rd, 2024
- CEO and Chairman of the Executive Board - European Biotechnology News - November 3rd, 2024
- The transformative potential of biotechnology and AI in healthcare - The Armchair Trader - November 3rd, 2024
- U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace - October 6th, 2024
- Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance - October 6th, 2024
- Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter - October 6th, 2024
- Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - AOL - October 6th, 2024
- Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -... - October 6th, 2024
- Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum - PR Newswire - October 6th, 2024
- Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter - October 6th, 2024
- Convergence is AIxBio: AI and the Bioeconomy - OODA Loop - October 6th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
- Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
- Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
- Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
- Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
- Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
- Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
- Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
- MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
- MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
- Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
- Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
- Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
- Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
- Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
- Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
- Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
- Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
- What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
- Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
- Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
- Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
- Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
- Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
- Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
- Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
- Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
- Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
- Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
- What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
- Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
- Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
- SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
- Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
- Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
- Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
- Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
- Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022